HomeRNXT • NASDAQ
RenovoRx Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.83M | -5.20% |
Net income | -2.47M | -73.89% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.56M | 196.44% |
Total assets | 10.03M | 185.05% |
Total liabilities | 2.96M | -15.74% |
Total equity | 7.07M | — |
Shares outstanding | 24.00M | — |
Price to book | 3.23 | — |
Return on assets | -64.17% | — |
Return on capital | -86.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.47M | -73.89% |
Cash from operations | -2.19M | 19.57% |
Cash from investing | — | — |
Cash from financing | 15.00K | — |
Net change in cash | -2.18M | 20.12% |
Free cash flow | -1.26M | 25.52% |
Previous close
$0.94
Day range
$0.95 - $0.98
Year range
$0.77 - $1.82
Market cap
22.66M USD
Avg Volume
172.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Website
Employees
10
